Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ART-Plan

K-Number: K230023 · 2023-04-19

ApplicantTherapanacea Sas
Decision Date2023-04-19
Product CodeQKB
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

ART-Plan is a medical device manufactured by Therapanacea Sas. It received FDA 510(k) clearance on 2023-04-19 under approval number K230023. The device is classified under product code QKB. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ART-Plan?

ART-Plan is a medical device that received FDA 510(k) clearance on 2023-04-19. It is manufactured by Therapanacea Sas. The 510(k) number is K230023.

When was ART-Plan approved by the FDA?

ART-Plan received FDA 510(k) clearance on 2023-04-19, under approval number K230023.

What company makes ART-Plan?

ART-Plan is manufactured by Therapanacea Sas.

What is the FDA product code for ART-Plan?

The FDA product code for ART-Plan is QKB.

Other Devices by Therapanacea Sas

K234068ART-Plan (v.2.2.0) K253091ART-Plan+ (v3.1.0) K242822ART-Plan+ (v.3.0.0)

Related Devices (Code: QKB)

K181572Workflow BoxMirada Medical, Ltd. K193562AI-Rad Companion Organs RTSiemens Medical Solutions USA, Inc. K200323AutoContourRadformation, Inc. K193252Contour ProtegeAIMim Software, Inc. K191928AccuContourXiamen Manteia Technology , Ltd. K213628VBrainVysioneer, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑